P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

March 2005

Features

Editor’s Memo

Drug Safety and the FDA

The FDA is hard at work on a variety of drug safety issues. Stay tuned.
Sonja Sherritze

The Dangers of Drug Importation

The authors review the reasons why drug importation is still prohibited.
Tanya Nelson, PharmD, and Jerilyn B. Petropoulos, BS, PharmD, BCPS

New FDA Initiatives in Response to the Problem of Counterfeit Drugs

Dr. Goldenberg explains some of the high-tech and low-tech initiatives being undertaken by the FDA to improve drug safety for consumers.
Marvin M. Goldenberg, PhD, RPh, MS

An Overview of the FDA’s Drug Shortage Program

As members of The Drug Shortage Team, the authors describe the causes of and some solutions to drug shortfalls.
CDR Valerie Jensen, RPh, Rene Kimzey, RNC, MEd, and LCDR Jouhayna Saliba, PharmD

The FDA’s Advisory Board on Drug Safety: The Right Medicine?

The newly created Drug Safety Oversight Board is a step in the right direction.
Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD

Managed Care’s Response to a Pharmacoeconomic Model of Serotonin Reuptake Inhibitors

The authors summarize the responses of participants at two roundtable discussions, held in 2004, to a new decision-analytic model of SRIs.
Patrick W. Sullivan, PhD, Robert Valuck, PhD, RPh, Diana I. Brixner, PhD, and Edward P. Armstrong, PharmD

Prevention of Medication Errors in the Hospital Setting: The Role of Pharmacy Students

The skills of pharmacy students can be useful in preventing errors in the areas of clinical appropriateness, administration, ordering, procedures, and dispensing.
Alan Caspi, PhD, PharmD, MBA, Vitalina Rozenfeld, PharmD, BCPS, and Jennie Kleyman, PharmD, BCPS

Departments

Editorial

The Leap to Electronic Prescribing

David Nash, MD, MBA, discusses the rationale for electronic prescribing and the contributions of the Leapfrog Group.
David Nash, MD, MBA

Letter to the Editor

Reflections on ‘Mirror, Mirror’

A. Mark Parker, MD, MSHA

Full and Timely Disclosure of Errors To Patients: Honesty Is the Best Policy

Matthew Grissinger, RPh, FASCP, explains why honesty is the best policy when it comes to disclosing medical errors to patients and their families.
Matthew Grissinger, RPh, FASCP

Prescription: Washington

Medicare Spells Out Rules for P&T Committees and Part D Drug Plan Benefits

Stephen Barlas reviews some of the rules that P&T committees will soon have to follow in relation to Part D Medicare benefits.
Stephen Barlas

New Drugs/Drug News/New Medical Devices

P&T presents the latest information about FDA approvals, drug indications, industry updates, and new devices.

Drug Forecast

The Role of Dexmedetomidine (Precedex®) in the Sedation of Critically Ill Patients

The authors review the agent dexmedetomidine (Precedex®) for the sedation of critically ill patients in the intensive care unit.
Diana Abramov, PharmD Candidate, Boris Nogid, PharmD, and Anna Nogid, PharmD